Hong-hao Ma
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Chronic active Epstein-Barr virus disease in children: Clinical outcomes and prognostic risk factors from a 149-patient cohort.
Journal: British journal of haematology
Published: January 07, 2026
Clinicopathologic Heterogeneity and Prognostic Determinants in Pediatric Chronic Active Epstein-Barr Virus Infection.
Journal: The Pediatric infectious disease journal
Published: December 05, 2025
Peripheral immune indicators and their predictive value in disease progression or relapse of pediatric Langerhans cell histiocytosis.
Journal: Jornal de pediatria
Published: July 07, 2025
Clinical Value of Proliferated T Lymphocytes With Aberrant Immunophenotypes in Childhood HLH.
Journal: Journal of pediatric hematology/oncology
Published: June 29, 2025
Cell-free BRAFV600E levels predict progression-free survival in children with Langerhans cell histiocytosis treated with dabrafenib and maintenance chemotherapy.
Journal: Haematologica
Published: February 11, 2025
The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis.
Journal: Jornal de pediatria
Published: May 17, 2024
Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis.
Journal: Archives of pathology & laboratory medicine
Published: March 18, 2024
The plasma-soluble CSF1R level is a promising prognostic indicator for pediatric Langerhans cell histiocytosis.
Journal: Pediatric blood & cancer
Published: January 25, 2024
Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in children.
Journal: British journal of haematology
Published: January 11, 2023
Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
Journal: American journal of hematology
Published: July 20, 2022
Development and application of an LC-MS/MS method for pharmacokinetic study of ruxolitinib in children with hemophagocytic lymphohistiocytosis.
Journal: Analytical methods : advancing methods and applications
Published: May 31, 2022
Last Updated: 09/26/2026